Ventas (NYSE:VTR) Rating Increased to Moderate Buy at Raymond James Financial

Ventas (NYSE:VTR) was upgraded by equities researchers at Raymond James Financial to a “moderate buy” rating in a research report issued to clients and investors on Tuesday,Zacks.com reports.

VTR has been the topic of several other research reports. BMO Capital Markets reiterated an “outperform” rating and set a $100.00 price target on shares of Ventas in a research note on Monday, May 4th. KeyCorp lifted their price target on shares of Ventas from $90.00 to $95.00 and gave the stock an “overweight” rating in a research note on Thursday, May 7th. JPMorgan Chase & Co. lifted their price target on shares of Ventas from $93.00 to $94.00 and gave the stock an “overweight” rating in a research note on Monday, May 11th. Mizuho set a $98.00 price target on shares of Ventas in a research note on Friday, May 22nd. Finally, Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and set a $100.00 price target on shares of Ventas in a research note on Tuesday. Fifteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $96.41.

Ventas Trading Down 2.0%

NYSE:VTR opened at $82.21 on Tuesday. The company has a current ratio of 0.25, a quick ratio of 0.25 and a debt-to-equity ratio of 0.95. Ventas has a 12 month low of $61.76 and a 12 month high of $91.06. The company has a market cap of $39.97 billion, a PE ratio of 149.48, a price-to-earnings-growth ratio of 1.80 and a beta of 0.71. The company has a 50 day simple moving average of $85.15 and a two-hundred day simple moving average of $82.58.

Ventas (NYSE:VTR) last posted its earnings results on Monday, April 27th. The real estate investment trust reported $0.11 EPS for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.01). Ventas had a return on equity of 2.09% and a net margin of 4.25%.The company had revenue of $1.65 billion during the quarter, compared to the consensus estimate of $1.59 billion. During the same period last year, the firm posted $0.84 EPS. The company’s revenue for the quarter was up 22.0% on a year-over-year basis. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. Research analysts forecast that Ventas will post 3.88 earnings per share for the current year.

Insider Buying and Selling at Ventas

In related news, Director Walter C. Rakowich sold 1,152 shares of Ventas stock in a transaction on Thursday, May 14th. The shares were sold at an average price of $90.20, for a total transaction of $103,910.40. Following the transaction, the director owned 28,349 shares in the company, valued at approximately $2,557,079.80. The trade was a 3.90% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Michael J. Embler bought 2,500 shares of the stock in a transaction that occurred on Wednesday, June 3rd. The shares were purchased at an average price of $78.81 per share, for a total transaction of $197,025.00. Following the purchase, the director owned 19,202 shares in the company, valued at $1,513,309.62. This represents a 14.97% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Company insiders own 0.53% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the company. Angeles Wealth Management LLC lifted its stake in shares of Ventas by 4.0% during the 1st quarter. Angeles Wealth Management LLC now owns 3,329 shares of the real estate investment trust’s stock valued at $274,000 after buying an additional 128 shares in the last quarter. Bridgewater Advisors Inc. lifted its stake in shares of Ventas by 2.0% during the 4th quarter. Bridgewater Advisors Inc. now owns 6,790 shares of the real estate investment trust’s stock valued at $525,000 after buying an additional 133 shares in the last quarter. IHT Wealth Management LLC lifted its stake in shares of Ventas by 3.2% during the 4th quarter. IHT Wealth Management LLC now owns 4,415 shares of the real estate investment trust’s stock valued at $343,000 after buying an additional 137 shares in the last quarter. True Wealth Design LLC lifted its stake in shares of Ventas by 32.0% during the 4th quarter. True Wealth Design LLC now owns 569 shares of the real estate investment trust’s stock valued at $44,000 after buying an additional 138 shares in the last quarter. Finally, Cigna Investments Inc. New lifted its stake in shares of Ventas by 3.3% during the 4th quarter. Cigna Investments Inc. New now owns 4,396 shares of the real estate investment trust’s stock valued at $341,000 after buying an additional 142 shares in the last quarter. Hedge funds and other institutional investors own 94.18% of the company’s stock.

Ventas Company Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.